Overview

Clinical Trial of Efficacy and Safety of Subetta in the Treatment of Impaired Glucose Tolerance

Status:
Completed
Trial end date:
2020-03-23
Target enrollment:
Participant gender:
Summary
Purpose of the study: - to assess the efficacy of Subetta in the treatment of impaired glucose tolerance - to assess the safety of Subetta in the treatment of impaired glucose tolerance.
Phase:
Phase 3
Details
Lead Sponsor:
Materia Medica Holding